Fig. 1From: Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosisAnti-CXCR3 and anti-CXCR4 antibody levels were strongly correlated in healthy donors (left) as well as in systemic sclerosis (SSc) patients (right)Back to article page
